YM155 inhibits retinal pigment epithelium cell survival through EGFR/MAPK signaling pathway
| Autor: | Yue Feng, Teng Li, Wen-Juan Lin, Hong-Bing Zhang, Xiao-Dong Chen, Bo Yuan, Jia-Min Meng |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
MAPK/ERK pathway
mitogen-activated protein kinase Cell growth Kinase business.industry Cell retinal pigment epithelial cell Cell biology 03 medical and health sciences Ophthalmology Basic Research 0302 clinical medicine medicine.anatomical_structure lcsh:Ophthalmology Epidermal growth factor Apoptosis Cell culture lcsh:RE1-994 030221 ophthalmology & optometry medicine Viability assay business epidermal growth factor receptor ym155 |
| Zdroj: | International Journal of Ophthalmology, Vol 14, Iss 4, Pp 489-496 (2021) Int J Ophthalmol |
| ISSN: | 2227-4898 2222-3959 |
| Popis: | AIM: To investigate YM155's effect on retinal pigment epithelium (RPE) cells' viability and the potential regulatory mechanisms. METHODS: Human immortalized RPE cell lines (ARPE-19 cell line) were processed with YM155 and epidermal growth factor (EGF). ARPE-19 cell viability was detected by methyl thiazolyl tetrazolium assay, and apoptosis was tested by flow cytometry assay. ARPE-19 cell proliferation was assessed with bromodeoxyuridine tagged incorporation assay, and migration ability was evaluated via a wound-healing assay. Epidermal growth factor receptor (EGFR)/MAPK pathway proteins were tested via immunoblotting. EGFR localization was examined by immunofluorescence assay. RESULTS: YM155 suppressed ARPE-19 cells' viability in a time and concentration-dependent manner. A high dose of YM155 caused a small amount of ARPE-19 cell death. YM155 significantly diminished the ARPE-19 cells' proliferative and migrative capacity. YM155 down-regulated total EGFR and phosphorylated external signal-regulated protein kinase (ERK), and it up-regulated the phosphorylation of P38MAPK and c-Jun N-terminal kinase (JNK). YM155 induced endocytosis of EGFR in ARPE-19 cell. YM155 also attenuated EGF-induced ARPE-19 cells' proliferative and migrative capacity. Moreover, YM155 significantly decreased the expression of phosphorylated EGFR and ERK after treated by EGF. CONCLUSION: YM155 inhibits RPE cell survival, the cell proliferative and migrative capacity, and it effectuates a small amount of cell death through the EGFR/MAPK signaling pathway. YM155 might, therefore, be an agent to prevent and treat abnormal RPE cell survival in proliferative vitreoretinopathy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|